GLYTHERA

Chemicals used in industry and science; chemical products for use in industry and science, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; reagents for use in scientific apparatus for chemical or biological analysis; reagents for medical research; in-vivo diagnostic reagents; chemical preparations for scientific and industrial processes, namely, vinyl pyridine-based linkers, vinyl pyridine derivatives, and difluorosialic acid; enzymes for scientific and industrial purposes; biological cell cultures for use in scientific research; all the aforementioned goods excluding goods in the field of gene therapy

Paper; cardboard; printed matter, namely, paper signs, books, manuals, business cards, newsletters, informational cards, posters, brochures, letters, data packages, certificates in the field of biotherapeutics; bookbinding material; photographs; stationery; Printed instructional, educational, and teaching materials in the field of medicine; publications, namely, books, hand-outs, workbooks, posters, research articles in the fields of science, medicine and biotherapeutics; publications for the medical profession, namely, magazines, newsletters, research articles in the field of medicine

Scientific and technological services, namely, scientific research, design, analysis and testing in the field of biotherapeutics for treating cancer; industrial analysis and research services, namely, synthetic chemistry, bioconjugation, and scientific analysis of antibody-drug conjugates and biotherapeutics; biological research; biotechnology testing services, namely, synthetic chemistry, recombinant protein production, bioconjugation, testing, analysis, and evaluation of antibody-drug conjugates and biotherapeutics to assure compliance with industry standards; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting clinical trials for others; design of clinical trials for others in the field of vaccines, biotherapeutics and antibody-drug conjugates; scientific research for medical purposes; scientific research for medical purposes in the area of cancerous diseases; information, advisory and consultancy services relating to the aforesaid; all the aforementioned services excluding services in the field of gene therapy